Trial Profile
Safety Study of ALG 1001 to Treat Diabetic Macular Edema
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 13 Dec 2012
Price :
$35
*
At a glance
- Drugs Risuteganib (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
- 05 Dec 2011 New trial record